Noom Science Advisory Board Lindsey Connors Lindsey Connors, Pharm.D is a highly skilled pharmacist with a diverse focus including long-term care, compounding pharmacy, consulting, clinical research, and technical writing
Yes medications are shipped directly to your home for convenience
The association between maternal body mass index and child obesity: a systematic review and meta-analysis
Following the recommended titration schedule and implementing dietary modifications can help minimise these effects and optimise treatment response
Safety Profile and Medical Considerations GLP-1 medications are prescription-strength pharmaceutical agents
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months